Daniel C Malone (Daniel Malone)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 30

Top Venues

Drug safety

Journal of medical Internet research

Journal of medical economics

Postgraduate medicine

University of Utah

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Utah Oct 01 2019

United States

Professor :: Pharmacotherapy

University of Arizona Aug 23 1999 - Sep 30 2019

United States

Professor

Publications

Julianna Catania, Steph Beaver, Rakshitha S Kamath, Emma Worthington, Minyi Lu, Hema Gandhi, Heidi C Waters, Daniel C Malone
Evaluation of Digital Mental Health Technologies in the United States: Systematic Literature Review and Framework Synthesis. JMIR mental health 11 (2024)
Khanh Ngoc Cong Duong, Dinh Van Nguyen, Nathorn Chaiyakunapruk, Richard E Nelson, Daniel C Malone
Cost-effectiveness of HLA-B*58:01 testing to prevent Stevens-Johnson syndrome/toxic epidermal necrolysis in Vietnam. Pharmacogenomics (2023)
Daniel C Malone, Ainhoa Gómez-Lumbreras, Richard D Boyce, Lorenzo Villa Zapata, Malinda S Tan, Philip D Hansten, John Horn
Reply: Drugs That Interact With Colchicine Via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS). The Annals of pharmacotherapy (2023)
Alexa C Klimchak, Lauren E Sedita, Katherine L Gooch, Daniel C Malone
Assessing the impact of single or short-term administration on a therapy's cost-effectiveness: a hypothetical disease-agnostic model. Journal of medical economics (2023)
Malinda S Tan, Ainhoa Gómez-Lumbreras, Lorenzo Villa Zapata, Daniel C Malone
Colchicine and macrolides: a cohort study of the risk of adverse outcomes associated with concomitant exposure. Rheumatology international 42 (12) (2022)
Daniel C Malone, Lorenzo Villa-Zapata, Ainhoa Gómez-Lumbreras, John Horn, Malinda S Tan, Richard D Boyce
Authors' Response to Yoshihiro Noguchi's Comment on: "A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)". Drug safety 45 (12) (2022)
Philip D Hansten, Malinda S Tan, John R Horn, Ainhoa Gomez-Lumbreras, Lorenzo Villa-Zapata, Richard D Boyce, Vignesh Subbian, Andrew Romero, Sheila Gephart, Daniel C Malone
Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based Management. Drug safety 46 (3) (2022)
Steven T Simon, Katy E Trinkley, Daniel C Malone, Michael Aaron Rosenberg
Interpretable Machine Learning Prediction of Drug-Induced QT Prolongation: Electronic Health Record Analysis. Journal of medical Internet research 24 (12) (2022)
Philip D Hansten, Malinda S Tan, John R Horn, Ainhoa Gomez-Lumbreras, Lorenzo Villa-Zapata, Richard D Boyce, Vignesh Subbian, Andrew Romero, Sheila Gephart, Daniel C Malone
Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based Management. Drug safety 46 (3) (2022)
Tyler Gallo, C William Heise, Raymond L Woosley, James E Tisdale, Malinda S Tan, Sheila M Gephart, Corneliu C Antonescu, Daniel C Malone
Clinician Responses to a Clinical Decision Support Advisory for High Risk of Torsades de Pointes. Journal of the American Heart Association 11 (11) (2022)
Ainhoa Gómez-Lumbreras, Thomas S Reese, Guilherme Del Fiol, Malinda S Tan, Jorie M Butler, Jason T Hurwitz, Mary L Brown, Kensaku Kawamoto, Henrik Thiess, Maria Wright, Daniel C Malone
Shared Decision-Making for Drug-Drug Interactions: Formative Evaluation of an Anticoagulant Drug Interaction. JMIR formative research 6 (10) (2022)
Lorenzo Villa Zapata, Ainhoa Gómez-Lumbreras, John R Horn, Malinda S Tan, Richard David Boyce, Daniel C Malone
A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS). Drug safety 45 (8) (2022)
Philip D Hansten, Malinda S Tan, John R Horn, Ainhoa Gomez-Lumbreras, Lorenzo Villa-Zapata, Richard D Boyce, Vignesh Subbian, Andrew Romero, Sheila Gephart, Daniel C Malone
Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based Management. Drug safety (2022)
Philip D Hansten, Malinda S Tan, John R Horn, Ainhoa Gomez-Lumbreras, Lorenzo Villa-Zapata, Richard D Boyce, Vignesh Subbian, Andrew Romero, Sheila Gephart, Daniel C Malone
Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based Management. Drug safety 46 (3) (2022)
Philip D Hansten, Malinda S Tan, John R Horn, Ainhoa Gomez-Lumbreras, Lorenzo Villa-Zapata, Richard D Boyce, Vignesh Subbian, Andrew Romero, Sheila Gephart, Daniel C Malone
Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based Management. Drug safety 46 (3) (2022)
Philip D Hansten, Malinda S Tan, John R Horn, Ainhoa Gomez-Lumbreras, Lorenzo Villa-Zapata, Richard D Boyce, Vignesh Subbian, Andrew Romero, Sheila Gephart, Daniel C Malone
Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based Management. Drug safety (2022)
Philip D Hansten, Malinda S Tan, John R Horn, Ainhoa Gomez-Lumbreras, Lorenzo Villa-Zapata, Richard D Boyce, Vignesh Subbian, Andrew Romero, Sheila Gephart, Daniel C Malone
Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based Management. Drug safety 46 (3) (2022)
Serena Jingchuan Guo, Walid F Gellad, Qingnan Yang, Jeremy C Weiss, Julie M Donohue, Gerald Cochran, Adam J Gordon, Daniel C Malone, Chian K Kwoh, Courtney C Kuza, Debbie L Wilson, Wei-Hsuan Lo-Ciganic
Changes in predicted opioid overdose risk over time in a state Medicaid program: a group-based trajectory modeling analysis. Addiction (Abingdon, England) 117 (8) (2022)
Fulton F Velez, Danmeng Huang, Lorie Mody, Daniel C Malone
Five-year budget impact of a prescription digital therapeutic for patients with opioid use disorder. Expert review of pharmacoeconomics & outcomes research 22 (4) (2022)
Thomas S Reese, Guilherme Del Fiol, Keaton L Morgan, Jason T Hurwitz, Kensaku Kawamoto, Ainhoa Gómez-Lumbreras, Mary L Brown, Henrik Thiess, Sara R Vazquez, Scott D Nelson, Richard David Boyce, Daniel C Malone
A Shared Decision-making Tool for Drug Interactions Between Warfarin and Nonsteroidal Anti-inflammatory Drugs: Design and Usability Study. JMIR human factors 8 (4) (2021)
Fulton F Velez, Hilary F Luderer, Robert Gerwien, Benjamin Parcher, Dylan Mezzio, Daniel C Malone
Evaluation of the cost-utility of a prescription digital therapeutic for the treatment of opioid use disorder. Postgraduate medicine 133 (4) (2021)
Lorenzo Villa Zapata, Philip D Hansten, John R Horn, Richard D Boyce, Sheila Gephart, Vignesh Subbian, Andrew Romero, Daniel C Malone
Evidence of Clinically Meaningful Drug-Drug Interaction With Concomitant Use of Colchicine and Clarithromycin. Drug safety 43 (7) (2021)
Claire L Simons, Daniel C Malone, Michael L Wang, Gregory A Maglinte, Timothy J Inocencio, Sally W Wade, Craig Bennison, Bijal D Shah
Cost-effectiveness for KTE-X19 CAR T therapy for adult patients with relapsed/refractory mantle cell lymphoma in the United States. Journal of medical economics 24 (1) (2021)
Yuri A Maricich, Robert Gerwien, Alice Kuo, Daniel C Malone, Fulton F Velez
Real-world use and clinical outcomes after 24 weeks of treatment with a prescription digital therapeutic for opioid use disorder. Hospital practice (1995) (2021)
Katy E Trinkley, Miranda E Kroehl, Michael G Kahn, Larry A Allen, Tellen D Bennett, Gary Hale, Heather Haugen, Simeon Heckman, David P Kao, Janet Kim, Daniel M Matlock, Daniel C Malone, Robert L Page, Jessica Stine, Krithika Suresh, Lauren Wells, Chen-Tan Lin
Applying Clinical Decision Support Design Best Practices With the Practical Robust Implementation and Sustainability Model Versus Reliance on Commercially Available Clinical Decision Support Tools: Randomized Controlled Trial. JMIR medical informatics 9 (3) (2021)
Fulton F Velez, Daniel C Malone
Cost-Effectiveness Analysis of a Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder. Journal of market access & health policy 9 (1) (2021)
Katy E Trinkley, Michael G Kahn, Tellen D Bennett, Russell E Glasgow, Heather Haugen, David P Kao, Miranda E Kroehl, Chen-Tan Lin, Daniel C Malone, Daniel M Matlock
Integrating the Practical Robust Implementation and Sustainability Model With Best Practices in Clinical Decision Support Design: Implementation Science Approach. Journal of medical Internet research 22 (10) (2020)
Sandipan Bhattacharjee, Suniya Naeem, Shannon M Knapp, Jeannie K Lee, Asad E Patanwala, Nina Vadiei, Daniel C Malone, Wei-Hsuan Lo-Ciganic, William J Burke
Health Outcomes Associated with Adherence to Antidepressant Use during Acute and Continuation Phases of Depression Treatment among Older Adults with Dementia and Major Depressive Disorder. Journal of clinical medicine 9 (10) (2020)
Amy J Grizzle, John R Horn, Carol Collins, Jodi Schneider, Daniel C Malone, Britney Stottlemyer, Richard David Boyce
Identifying Common Methods Used by Drug Interaction Experts for Finding Evidence About Potential Drug-Drug Interactions: Web-Based Survey. Journal of medical Internet research 21 (1) (2019)
Shelagh M Szabo, Ivana F Audhya, Daniel C Malone, David Feeny, Katherine L Gooch
Characterizing health state utilities associated with Duchenne muscular dystrophy: a systematic review. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 29 (3) (2019)

Daniel C Malone.css-eqlu8i{font-size:small;padding-left:4px;} (Daniel Malone)

Publication Activity (10 Years)

Top Topics

Top Venues

Daniel C Malone (Daniel Malone)